425: Monroe Capital to Merge with Horizon Finance After Asset Sale

Monroe Capital Corporation announces a two-step transaction involving an asset sale to Monroe Capital Income Plus Corporation followed by a merger with Horizon Finance Technology.

Summary

• Monroe Capital Corporation (MRCC) has entered into agreements for a two-step transaction: an asset sale and a merger.
• MRCC will sell substantially all of its investment assets to Monroe Capital Income Plus Corporation (MCIP) for cash at fair value, determined shortly before the closing date.
• Immediately following the asset sale, MRCC will merge with HMMS, Inc., a wholly-owned subsidiary of Horizon Finance Technology (HRZN), with MRCC as the surviving company, which will then immediately merge into HRZN, with HRZN as the surviving entity.
• The mergers are intended to be treated as a tax-free reorganization under Section 368(a) of the Internal Revenue Code.
• MRCC shareholders will receive shares of HRZN common stock based on an Exchange Ratio, calculated as MRCC's Net Asset Value (NAV) per share divided by HRZN's NAV per share, both determined as of a mutually agreed date no earlier than 48 hours prior to the effective time.
• No fractional shares of HRZN common stock will be issued; MRCC holders will receive cash in lieu of fractional shares.
• Horizon Technology Finance Management LLC (HRZN Advisor) has agreed to waive $4.0 million in Base Management Fees and/or Incentive Fees, at a rate of $1.0 million per quarter, for four full fiscal quarters following the closing of the mergers.
• The transactions are currently anticipated to close during the fourth quarter of 2025.
• If the Merger Agreement is terminated due to a superior alternative proposal for HRZN, HRZN may be required to pay MRCC a termination fee of approximately $11 million.
• If the Merger Agreement is terminated due to a superior alternative proposal for MRCC, the third-party acquirer may be required to pay HRZN a termination fee of approximately $5.4 million.
• If the Asset Purchase Agreement is terminated due to a superior alternative proposal for MRCC, the third-party acquirer may be required to pay MCIP a termination fee of approximately $5.4 million.

Sentiment

Score: 7

Explanation: The filing announces a strategic two-step transaction designed to be tax-free for shareholders, involving an asset sale and a merger, with a significant fee waiver from the acquiring entity's advisor. This indicates a positive strategic move for the companies involved, aiming for enhanced operational efficiency and shareholder value. However, inherent risks associated with merger completion, regulatory approvals, and potential litigation are present, warranting a moderately positive sentiment.

Positives

• The mergers are intended to be treated as a tax-free reorganization for U.S. federal income tax purposes, which is beneficial for shareholders.
• HRZN Advisor will waive $4.0 million in management and incentive fees over four quarters post-merger, potentially enhancing the combined entity's financial performance.
• The boards of directors of both MRCC and HRZN, including their respective independent directors and special committees, have unanimously approved the Merger Agreement and the transactions, indicating strong internal support.
• The MRCC Special Committee received a fairness opinion from Houlihan Lokey Capital, Inc., confirming the Exchange Ratio was fair from a financial point of view to MRCC common stockholders (excluding affiliates).
• MCIP has confirmed it has immediately available funds or commitments to pay the full Purchase Price for MRCC's assets.

Negatives

• The transactions are subject to various closing conditions, including stockholder and regulatory approvals, which may not be obtained.
• Termination fees of up to $11 million could be payable if the agreements are terminated under certain conditions, such as acceptance of a superior alternative proposal.
• There is a risk of shareholder litigation in connection with the proposed transactions, which could result in significant defense costs and liabilities.
• Management's attention may be diverted from ongoing business operations due to the complexity of the transactions.
• The ability to realize anticipated benefits, synergies, and savings from the proposed transactions is not guaranteed.

Risks

• Uncertainty regarding the timing or likelihood of the proposed transactions closing.
• Inability to realize the anticipated benefits, synergies, and savings associated with the proposed transactions.
• Governmental entities may prohibit, delay, or refuse to grant approval for the consummation of the proposed transactions, or may require conditions, limitations, or restrictions in connection with such approvals.
• Required approvals by the shareholders of MRCC and/or HRZN may not be obtained.
• Possibility that competing offers or acquisition proposals will be made.
• Risks related to diverting management's attention from ongoing business operations.
• Shareholder litigation in connection with the proposed transactions may result in significant costs of defense and liability.
• Changes in the economy, financial markets, and political environment, including the impacts of inflation and interest rates.
• Risks associated with possible disruption in operations due to terrorism, war or other geopolitical conflict, natural disasters, tariffs, or public health crises and epidemics.
• Future changes in laws or regulations (including the interpretation of these laws and regulations by regulatory authorities).
• Conditions in Business Development Company (BDC) or regulated investment company operating areas.
• No assurance that the market price of HRZN's shares, either absolutely or relative to net asset value, will increase as a result of the merger, or that any repurchase plan will enhance shareholder value over the long term.
• Potential for material adverse effects on the business, operations, condition (financial or otherwise), or results of operations of MRCC or HRZN.
• Failure to obtain necessary consents for the transfer of certain assets (Restricted Assets or Delayed Transfer Assets) could delay or complicate their transfer to MCIP.

Future Outlook

The transactions are currently anticipated to close during the fourth quarter of 2025. The parties intend for the mergers to be treated as a reorganization within the meaning of Section 368(a) of the Internal Revenue Code. Following the mergers, HRZN plans and intends to continue at least one significant historic business line of MRCC, or to use a significant portion of MRCC's historic business assets in a business.

Management Comments

• The MRCC Board, including all of its Independent Directors, unanimously determined that the Merger Agreement and the terms of the Mergers and the Transactions are advisable and in the best interests of MRCC, and that the interests of MRCC's existing stockholders will not be diluted.
• The HRZN Board, including all of its Independent Directors, unanimously determined that the Merger Agreement and the terms of the Mergers and the Transactions are advisable and in the best interests of HRZN, and that the interests of HRZN's existing stockholders will not be diluted.
• Monroe Advisor believes that participation in the Asset Purchase and Mergers is in the best interests of MRCC and MCIP, and that the interests of existing stockholders of MRCC and MCIP will not be diluted.
• HRZN Advisor believes that participation in the Mergers is in the best interests of HRZN, and that the interests of existing stockholders of HRZN will not be diluted.

Industry Context

This filing details a strategic consolidation within the Business Development Company (BDC) sector, involving an asset transfer and subsequent merger between three BDCs (MRCC, MCIP, and HRZN). Such transactions are common in the financial services industry as companies seek to achieve scale, optimize asset management, and enhance shareholder value through synergies and efficiencies. The involvement of shared investment advisors (Monroe Advisor for MRCC and MCIP) and the structured compliance with the Investment Company Act of 1940 highlight the regulatory complexities and the importance of corporate governance in this specialized financial segment. The fee waiver by HRZN Advisor is a notable incentive, potentially setting a precedent for future BDC consolidations aimed at improving post-merger financial attractiveness.

Comparison to Industry Standards

• The transactions are structured to comply with the safe harbor provision of Rule 17a-8 of the Investment Company Act of 1940, which is a key regulatory standard for transactions involving affiliated persons within the BDC industry.
• Both MRCC and HRZN have consistently qualified as Regulated Investment Companies (RICs) for many years (MRCC since 2012, HRZN since 2010), demonstrating adherence to the tax requirements for BDCs, which is a standard for maintaining favorable tax treatment.
• The unanimous approval by the boards of directors, including independent directors and special committees, for both the Merger Agreement and Asset Purchase Agreement, aligns with best practices in corporate governance for complex transactions to ensure fairness and protect shareholder interests.
• The provision for indemnification and D&O tail insurance for directors and officers for six years post-merger is a standard practice in M&A to protect past and present management, comparable to provisions seen in other financial sector mergers.
• The requirement for MRCC to maintain greater than 70% of its total assets as qualifying investments for Section 55(a) of the Investment Company Act is a fundamental regulatory compliance benchmark for BDCs, ensuring their continued status and operational focus.

Management Changes

Corporate Governance

Legal Proceedings

• No material proceedings are pending or, to the knowledge of MRCC or HRZN, threatened against either company or their consolidated subsidiaries.
• No material orders are binding upon MRCC or HRZN or their consolidated subsidiaries.
• The parties will cooperate and consult in the defense and settlement of any shareholder litigation related to the agreements or transactions, and no settlement can occur without prior written consent of the other party.

Related Party Transactions

• Monroe Capital Corporation (MRCC) is selling substantially all of its investment assets to Monroe Capital Income Plus Corporation (MCIP), and both entities are advised by Monroe Capital BDC Advisors, LLC (Monroe Advisor), indicating a related-party transaction.
• The transactions are structured to comply with Rule 17a-8 of the Investment Company Act of 1940, which provides a safe harbor for certain transactions between affiliated persons, addressing the related-party nature of the asset sale and subsequent merger.

Stakeholder Impact

• Shareholders of MRCC: Will receive HRZN common stock in a transaction intended to be a tax-free reorganization, subject to their approval. Their interests are explicitly stated as not expected to be diluted.
• Shareholders of HRZN: Will see new shares issued as merger consideration, subject to their approval. Their interests are explicitly stated as not expected to be diluted.
• Investment Advisors (Monroe Advisor & HRZN Advisor): HRZN Advisor will waive $4.0 million in fees post-merger. Monroe Advisor is involved in the asset sale to MCIP. The MRCC Advisory Agreement and MRCC Administration Agreement will terminate.
• Portfolio Companies: MRCC's investment assets (loans and equity interests) will be acquired by MCIP, implying a change in the legal holder of these investments, though the underlying investment advisor (Monroe Advisor) remains involved with MCIP.
• Employees: Neither MRCC nor HRZN has direct employees; their operations are managed by their respective investment advisors. No direct impact on employees is mentioned.

Next Steps

• MRCC and HRZN will jointly prepare and file a registration statement on Form N-14 with the SEC, which will include a joint proxy statement/prospectus.
• HRZN will use reasonable best efforts to have the registration statement declared effective and keep it effective until the mergers are consummated.
• MRCC and HRZN will promptly mail the joint proxy statement/prospectus to their respective stockholders upon effectiveness.
• MRCC and HRZN will convene and hold stockholder meetings to obtain the required approvals for the Asset Sale and Mergers.
• Obtain all necessary regulatory approvals, including the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976.
• MRCC will declare and pay a Tax Dividend for all taxable years ending prior to or with the Effective Time.
• MRCC will deliver a FIRPTA certificate to HRZN within 30 days prior to the Closing Date.
• HRZN will use reasonable best efforts to cause the shares of HRZN Common Stock to be issued as Merger Consideration to be approved for listing on the Nasdaq.
• HRZN and HRZN Advisor will enter into a fee waiver agreement immediately after the Second Effective Time.
• HRZN and MRCC will coordinate record and payment dates for any quarterly dividends or distributions in the calendar quarter when closing is expected.

Key Dates

Recommendation

The filing details a complex, multi-step strategic transaction involving an asset sale and a merger, structured to be tax-free for shareholders, and includes a significant fee waiver from the acquiring entity's advisor. While these elements suggest potential long-term benefits through consolidation and operational efficiencies, the successful execution of such transactions carries inherent risks, including obtaining all necessary regulatory and shareholder approvals, potential for competing offers, and the challenges of integration. The full financial impact and synergies are yet to be realized. Therefore, a 'hold' recommendation is appropriate to allow investors to monitor the progression of the transaction and its initial post-closing performance before making a more definitive investment decision.

Keywords

Business Development Company, BDC, Merger, Acquisition, Asset Sale, SEC Filing, Corporate Finance, Investment Management, Financial Services, MRCC, HRZN, MCIP, Tax-Free Reorganization